Literature DB >> 28249818

"The new pH-centric anticancer paradigm in Oncology and Medicine"; SCB, 2017.

Salvador Harguindey, Stephan J Reshkin.   

Abstract

Year:  2017        PMID： 28249818     DOI： 10.1016/j.semcancer.2017.02.008

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN： 1044-579X            Impact factor:   15.707


× No keyword cloud information.
  12 in total

1.  Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer.

Authors:  Larry Fliegel
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

2.  PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination therapy.

Authors:  Priyanka Ray; Matthew Confeld; Pawel Borowicz; Tao Wang; Sanku Mallik; Mohiuddin Quadir
Journal:  Colloids Surf B Biointerfaces       Date:  2018-10-28       Impact factor: 5.268

Review 3.  Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies.

Authors:  Salvador Harguindey; Julian Polo Orozco; Khalid O Alfarouk; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2019-09-01       Impact factor: 5.923

Review 4.  The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer.

Authors:  Khalid O Alfarouk; Samrein B M Ahmed; Ahmed Ahmed; Robert L Elliott; Muntaser E Ibrahim; Heyam S Ali; Christian C Wales; Ibrahim Nourwali; Ahmed N Aljarbou; Adil H H Bashir; Sari T S Alhoufie; Saad Saeed Alqahtani; Rosa A Cardone; Stefano Fais; Salvador Harguindey; Stephan J Reshkin
Journal:  Cancers (Basel)       Date:  2020-04-07       Impact factor: 6.639

5.  Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment.

Authors:  Traian Sulea; Nazanin Rohani; Jason Baardsnes; Christopher R Corbeil; Christophe Deprez; Yuneivy Cepero-Donates; Alma Robert; Joseph D Schrag; Marie Parat; Mélanie Duchesne; Maria L Jaramillo; Enrico O Purisima; John C Zwaagstra
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

6.  Outcomes Assessment of Sustainable and Innovatively Simple Lifestyle Modification at the Workplace - Drinking Electrolyzed-Reduced Water (OASIS-ERW): A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Young Ah Choi; Dong Hyeon Lee; Doo-Yeoun Cho; Yong-Jae Lee
Journal:  Antioxidants (Basel)       Date:  2020-06-27

7.  Curing cancer? Further along the new pH-centric road and paradigm.

Authors:  S Harguindey; T Koltai; S J Reshkin
Journal:  Oncoscience       Date:  2018-06-24

Review 8.  A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Kevin Hardonniere; Daniel Stanciu; Stefano Fais; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

9.  Carbonic Anhydrase Inhibitor Acetazolamide Enhances CHOP Treatment Response and Stimulates Effector T-Cell Infiltration in A20/BalbC Murine B-Cell Lymphoma.

Authors:  Gábor Méhes; Orsolya Matolay; Lívia Beke; Marianna Czenke; Róbert Pórszász; Edit Mikó; Péter Bai; Ervin Berényi; György Trencsényi
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923

Review 10.  Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Stefano Fais; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.